About UE LifeSciences
UE LifeSciences is a company based in Philadelphia (United States) founded in 2009 by Bhaumik Sanghvi, Matthew Campisi, and Mihir Shah. It operates as a HealthTech, and Direct-to-Consumer (D2C). UE LifeSciences has raised $4.76 million across 6 funding rounds from investors including Aarin Capital, Capria and Kiran Mazumdar Shaw. The company has 42 employees as of March 29, 2024. UE LifeSciences offers products and services including iBreastExam, CervAIcal, and OrCA. UE LifeSciences operates in a competitive market with competitors including Vayyar, Niramai, CairnSurgical, CMR Naviscan and Dune Medical, among others.
- Headquarter Philadelphia, United States
- Employees 42 as on 29 Mar, 2024
- Founders Bhaumik Sanghvi, Matthew Campisi, Mihir Shah
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ue Lifesciences Inc.
- Date of Incorporation 28 Sep, 2015
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$1.54 M (USD)239.89as on Mar 31, 2023
-
Net Profit
$133.8 K (USD)-4.01as on Mar 31, 2023
-
EBITDA
$154.22 K (USD)-31.74as on Mar 31, 2023
-
Total Equity Funding
$4.76 M (USD)
in 6 rounds
-
Latest Funding Round
$480.31 K (USD), Series A
Nov 23, 2021
-
Investors
Aarin Capital
& 3 more
-
Employee Count
42
as on Mar 29, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of UE LifeSciences
UE LifeSciences offers a comprehensive portfolio of products and services, including iBreastExam, CervAIcal, and OrCA. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Breast lump detection tool used for early screening.
Mobile colposcope designed for cervical cancer screening.
Oral cancer assessment tool for early detection.
Unlock access to complete
Unlock access to complete
Funding Insights of UE LifeSciences
UE LifeSciences has successfully raised a total of $4.76M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $480.31 thousand completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $480,308
-
First Round
First Round
(20 Aug 2012)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series A - UE LifeSciences | Valuation |
investors |
|
| Oct, 2016 | Amount | Series A - UE LifeSciences | Valuation | Kiran Mazumdar Shaw | |
| Jun, 2016 | Amount | Series A - UE LifeSciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in UE LifeSciences
UE LifeSciences has secured backing from 4 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Aarin Capital, Capria and Kiran Mazumdar Shaw. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in applied generative AI
|
Founded Year | Domain | Location | |
|
Venture funding in technology-intensive businesses within healthcare, education, and India-centric markets.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by UE LifeSciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - UE LifeSciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ue Lifesciences Comparisons
Competitors of UE LifeSciences
UE LifeSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vayyar, Niramai, CairnSurgical, CMR Naviscan and Dune Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of 4D imaging sensors for cancer detection and other devices
|
|
| domain | founded_year | HQ Location |
Early breast cancer is detected using AI-based non-invasive thermal imaging.
|
|
| domain | founded_year | HQ Location |
Developer of 3D printed surgical guides for breast cancer treatment
|
|
| domain | founded_year | HQ Location |
High-resolution PET scanners for breast imaging are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Intraoperative cancer detection devices are developed for real-time tissue assessment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ue Lifesciences
Frequently Asked Questions about UE LifeSciences
When was UE LifeSciences founded?
UE LifeSciences was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Where is UE LifeSciences located?
UE LifeSciences is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Who is the current CEO of UE LifeSciences?
Mihir Shah is the current CEO of UE LifeSciences. They have also founded this company.
Is UE LifeSciences a funded company?
UE LifeSciences is a funded company, having raised a total of $4.76M across 6 funding rounds to date.
How many employees does UE LifeSciences have?
As of Mar 29, 2024, the latest employee count at UE LifeSciences is 42.
What is the annual revenue of UE LifeSciences?
Annual revenue of UE LifeSciences is $1.54M as on Mar 31, 2023.
What does UE LifeSciences do?
UE LifeSciences is engaged in developing hand-held, non-invasive medical devices for early cancer detection. Solutions are designed for breast, cervical, and oral cancer screening, targeting accessibility and effectiveness. The company operates in multiple global markets, including India, USA, Malaysia, and Colombia. Innovations are tailored for use by community health workers with minimal training. Multi-cancer screening initiatives are integrated for large-scale implementation. Partnerships with global health organizations and governments are maintained to address disparities in early detection.
Who are the top competitors of UE LifeSciences?
UE LifeSciences's top competitors include CairnSurgical, Niramai and Micrima.
What products or services does UE LifeSciences offer?
UE LifeSciences offers iBreastExam, CervAIcal, and OrCA.
Who are UE LifeSciences's investors?
UE LifeSciences has 4 investors. Key investors include Aarin Capital, Capria, Kiran Mazumdar Shaw, and Caricainvestments.